Ladderbio
Blue Bell, US Β· 2 known investors
Ladder Bio (formerly ThirdLaw Molecular) develops Spiroligomer molecules, a class of synthetic, modular fused-ring compounds designed for highly selective binding to target proteins, along with computational design tools for targeted drug discovery. The platform is aimed at creating therapeutics and diagnostic tests as synthetic alternatives to peptides and antibodies.
Founders & leadership
Investors Β· 2
Frequently asked questions
- What does Ladderbio do?
- Ladder Bio (formerly ThirdLaw Molecular) develops Spiroligomer molecules, a class of synthetic, modular fused-ring compounds designed for highly selective binding to target proteins, along with computational design tools for targeted drug discovery. The platform is aimed at creating therapeutics and diagnostic tests as synthetic alternatives to peptides and antibodies.
- Who founded Ladderbio?
- Ladderbio was founded by Christian Schafmeister.
- Who are Ladderbio's investors?
- Ladderbio's investors include Medical Excellence Capital, SmartGateVC.
- Where is Ladderbio headquartered?
- Ladderbio is headquartered in Blue Bell, US.